Emergency icon Important Updates

Reza Alaghehbandan, MD

Reza Alaghehbandan, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Pathology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.445.2097
Fax:
216.445.3707
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Reza Alaghehbandan, MD

Reza Alaghehbandan, MD, is a Surgical Pathologist with expertise in urologic pathology as well as a Clinical Epidemiologist. He is board-certified in Anatomic Pathology in the USA, Canada, and Europe, and is a distinguished Fellow of the American College of Epidemiology (FACE) and the New York Academy of Medicine (NYAM). Prior to joining the Cleveland Clinic team, he served as Clinical Professor of Pathology at the University of British Columbia (UBC) and the Department Head of Pathology at Royal Columbian Hospital in Vancouver, BC, Canada.

Dr. Alaghehbandan’s primary research focus is on diagnostic and prognostic challenges in urologic pathology, with emphasis on recognizing novel renal tumor histologic features that correlate with underlying molecular signatures and significance for patient management and outcomes. He is a frequent speaker at national and international conferences and has authored numerous peer-reviewed articles.

Further to his scholarly activities, Dr. Alaghehbandan has served in various leadership and administrative roles and held positions in national and international committees. As a physician philanthropist, he has served as an International Academy of Pathology (IAP) Ambassador, with passion for global health and building capacity and highlighting the improvements pathologists can make for populations in resource-poor settings. He continues to provide teaching and expertise in clinical services and translational research in low- and middle-income countries.

His goal is to make a lasting impact in the world of global health and cancer control.
Education & Professional Highlights

Education & Professional Highlights

Appointed
2022

Education & Fellowships

Fellowship - Barnes-Jewish Hospital/Washington University School of Medicine
Surgical (Selective) Pathology
St. Louis, MO United States
2014

Residency - Memorial University of Newfoundland Faculty of Medicine
Anatomic Pathology
St. John's, Newfoundland, NL Canada
2013

Residency - University of British Columbia Faculty of Medicine (Canada)
Anatomic Pathology
Vancouver, British Columbia, Canada
2012

Medical Education - Iran University of Medical Sciences
Tehran, Iran
2000

Internship - Iran University of Medical Sciences
Rotational
Tehran, Iran
1998

Certifications

  • Anatomic Pathology
  • Pathology - Anatomic Pathology
Research & Publications

Research & Publications

See publications for Reza Alaghehbandan, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/29/2023, Dr. Alaghehbandan has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top